Adverse events72

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 72

Type	Event	Organ system	Group	Affected	At risk	Events
other	Aldolase Increase	Investigations	Intervention Group (Atorvastatin)	2	27	2
other	Aldolase Increase	Investigations	Control Group (Placebo)	3	28	3
other	ACE Level increased	Investigations	Intervention Group (Atorvastatin)	2	27	2
other	ACE Level increased	Investigations	Control Group (Placebo)	1	28	1
other	Alkaline Phosphatase Increase	Investigations	Intervention Group (Atorvastatin)	3	27	3
other	Alkaline Phosphatase Increase	Investigations	Control Group (Placebo)	1	28	1
other	Alanine aminotransferase Increased	Investigations	Intervention Group (Atorvastatin)	13	27	13
other	Alanine aminotransferase Increased	Investigations	Control Group (Placebo)	4	28	4
other	Asparatate aminotransferase Increased	Investigations	Intervention Group (Atorvastatin)	14	27	14
other	Asparatate aminotransferase Increased	Investigations	Control Group (Placebo)	5	28	5
other	Amylase Increased	Investigations	Intervention Group (Atorvastatin)	0	27	0
other	Amylase Increased	Investigations	Control Group (Placebo)	4	28	4
other	Bronchial Infection	Respiratory, thoracic and mediastinal disorders	Intervention Group (Atorvastatin)	0	27	0
other	Bronchial Infection	Respiratory, thoracic and mediastinal disorders	Control Group (Placebo)	2	28	2
other	Bronchospasm	Respiratory, thoracic and mediastinal disorders	Intervention Group (Atorvastatin)	2	27	2
other	Bronchospasm	Respiratory, thoracic and mediastinal disorders	Control Group (Placebo)	0	28	0
other	Creatine Phosphokinase increased	Investigations	Intervention Group (Atorvastatin)	2	27	2
other	Creatine Phosphokinase increased	Investigations	Control Group (Placebo)	3	28	3
other	Creatinine increased	Investigations	Intervention Group (Atorvastatin)	0	27	0
other	Creatinine increased	Investigations	Control Group (Placebo)	4	28	4

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00279708/events

API reference For AI assistants

Adverse events72

Sources 3

Read this list from software.